• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.14% Nasdaq Down 0.35%

    More On REPCF

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    RepliCel Life Sciences Inc. (REPCF)

    -Other OTC
    0.30 Up 0.01(4.15%) Sep 3, 1:52PM EDT
    Add to Portfolio
    Prev Close:0.31
    Open:0.28
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:0.819533
    Next Earnings Date:N/A
    Day's Range:0.28 - 0.30
    52wk Range:0.24 - 0.58
    Volume:2,483
    Avg Vol (3m):7,098
    Market Cap:18.01M
    P/E (ttm):N/A
    EPS (ttm):-0.07
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for REPCF

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments are based on autologous cell therapy, which isolates an individual’s own cel... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback